[
    [
        {
            "time": "",
            "original_text": "凯莱英今日大宗交易成交25万股，成交价67.5元折价9.24%",
            "features": {
                "keywords": [
                    "凯莱英",
                    "大宗交易",
                    "成交价",
                    "折价"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "凯莱英今日大宗交易成交25万股，成交价67.5元折价9.24%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "[审慎增持评级]凯莱英(002821)中报点评：业绩高增长 新业务不断推进",
            "features": {
                "keywords": [
                    "凯莱英",
                    "中报",
                    "业绩高增长",
                    "新业务"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[审慎增持评级]凯莱英(002821)中报点评：业绩高增长 新业务不断推进",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[中性评级]深度*行业*医药生物行业周报：维持龙头白马配置 关注长期调整处于底部区域品种",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业周报",
                    "龙头白马",
                    "长期调整",
                    "底部区域"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[中性评级]深度*行业*医药生物行业周报：维持龙头白马配置 关注长期调整处于底部区域品种",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]